KREBSBIO.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:20):

Stats
Šios dienos apimtis	595.00
Vidutinė apimtis	14 948.00
Rinkos kapitalizacija	1.57B
EPS	INR0 ( 2024-02-11 )
Kita pelno data	( INR0 ) 2024-05-21
Last Dividend	INR2.90 ( 2005-09-14 )
Next Dividend	INR0 ( N/A )
P/E	-7.63
ATR14	INR0.289 (0.40%)

Krebs Biochemicals & Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Krebs Biochemicals & Finansinės ataskaitos

Annual	2022
Pajamos:	INR521.34M
Bruto pelnas:	INR264.57M (50.75 %)
EPS:	INR-11.45

FY	2022
Pajamos:	INR521.34M
Bruto pelnas:	INR264.57M (50.75 %)
EPS:	INR-11.45

FY	2022
Pajamos:	INR529.41M
Bruto pelnas:	INR-207.59M (-39.21 %)
EPS:	INR-20.74

FY	2021
Pajamos:	INR386.06M
Bruto pelnas:	INR-136.26M (-35.29 %)
EPS:	INR-14.53

Financial Reports:

No articles found.

Krebs Biochemicals & Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Krebs Biochemicals & Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 3.18 - No dividend growth expected in the near future

Information

First Dividend	INR2.90	2005-09-14
Last Dividend	INR2.90	2005-09-14
Next Dividend	INR0	N/A
Payout Date	2005-10-01
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR2.90	--
Avg. Dividend % Per Year	0.00%	--
Score	0.38	--
Div. Sustainability Score	0
Div.Growth Potential Score	3.18
Div. Directional Score	1.228	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.38

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SANDHAR.NS	Dividend Junior	2023-09-14	Annually	7	0.66%
LXCHEM.NS	Dividend Junior	2023-07-20	Annually	4	0.11%
GLENMARK.NS	Dividend Junior	2023-09-18	Annually	23	0.37%
ASIANPAINT.NS	Dividend Junior	2023-06-09	Semi-Annually	23	0.43%
TINPLATE.NS	Dividend Junior	2023-08-11	Annually	19	0.72%
PDMJEPAPER.NS	Dividend Junior	2023-08-03	Annually	9	0.65%
J&KBANK.NS	Dividend Junior	2023-08-17	Sporadic	22	0.47%
DATAMATICS.NS	Dividend Junior	2023-09-22	Annually	21	0.49%
SHYAMMETL.NS	Dividend Junior	2023-06-05	Semi-Annually	4	0.70%
MAXHEALTH.NS	Dividend Junior	2023-09-08	Insufficient data to determine frequency	2	0.07%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.417	1.500	-8.34	-10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.200	1.500	8.88	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	-3.69	1.000	-2.48	-2.48	[3 - 30]
operatingCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	6.10	2.00	6.95	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.739	1.000	1.015	1.015	[0.2 - 0.8]
operatingProfitMarginTTM	-0.329	1.000	-8.57	-8.57	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				-0.725

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.56	1.000	-0.865	0	[1 - 100]
returnOnEquityTTM	0.200	2.50	9.28	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	6.10	2.00	7.97	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.176	1.500	-2.16	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.263	1.000	5.91	0	[0.1 - 0.5]
Total Score				3.18

Krebs Biochemicals &

Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry fields. Its products, such as androstenedione, lovastatin, and simvastatin for anti-cholesterol and steroid intermediate applications. The company is also developing various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. Krebs Biochemicals & Industries Limited was incorporated in 1991 and is headquartered in Hyderabad, India.